Overview

Intensive Versus Standard Blood Pressure Lowering to Prevent Functional Decline in Older People

Status:
Active, not recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
This study will evaluate different treatment strategies for high blood pressure using medications approved by the US Food and Drug Administration (FDA) for the treatment of high blood pressure. The study will compare the effects of an intensive reduction of 24-hour average blood pressure to a standard reduction of 24-hour mean blood pressure on controlling declines in mobility (speed and agility of walking) and cognition (ability to think and process information) in an aging population.
Phase:
Phase 4
Details
Lead Sponsor:
UConn Health
Collaborator:
National Institute on Aging (NIA)
Treatments:
Angiotensin-Converting Enzyme Inhibitors
Calcium Channel Blockers